about
Immune responses to HBsAg conjugated to protein D of non-typeable Haemophilus influenzae in micePrevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, ChinaHemagglutinin and neuraminidase matching patterns of two influenza A virus strains related to the 1918 and 2009 global pandemics.Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.The structural characterization and antigenicity of the S protein of SARS-CoV.Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis A virus infection in vitro and in vivo.Whole-gene analysis of two groups of hepatitis B virus C/D inter-genotype recombinant strains isolated in Tibet, ChinaMultiplex hydrolysis probe real-time PCR for simultaneous detection of hepatitis A virus and hepatitis E virusEpidemiology of hepatitis E virus in China: results from the Third National Viral Hepatitis Prevalence Survey, 2005-2006Prevalence of human parvovirus B19, bocavirus, and PARV4 in blood samples from the general population of China and lack of a correlation between parvovirus and hepatitis B co-infectionGenetic diversity of hepatitis A virus in China: VP3-VP1-2A genes and evidence of quasispecies distribution in the isolatesRisk factors of hepatitis C virus transmission and genotype distribution in former blood donors from Chinese rural area.Enhanced mucosal immune responses induced by a combined candidate mucosal vaccine based on Hepatitis A virus and Hepatitis E virus structural proteins linked to tuftsinProtective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model.Construction and Immunological Evaluation of CpG-Au@HBc Virus-Like Nanoparticles as a Potential Vaccine.Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in China.Hepatitis A outbreaks in China during 2006: application of molecular epidemiology.Complete genome sequences of the SARS-CoV: the BJ Group (Isolates BJ01-BJ04).The E protein is a multifunctional membrane protein of SARS-CoV.The structure analysis and antigenicity study of the N protein of SARS-CoV.Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.Development of a sandwich ELISA for the quantification of enterovirus 71.Reprint of: Epidemiological serosurvey of Hepatitis B in China--declining HBV prevalence due to Hepatitis B vaccination.Long-term effectiveness of plasma-derived hepatitis B vaccine 22-28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed?The long-term efficacy of Chinese hamster ovary cell derived hepatitis B vaccine after being used for 14-16 years in Chinese rural communities.Hepatitis C virus envelope glycoproteins complementation patterns and the role of the ecto- and transmembrane domains.Hepatitis B Immunoprophylactic Failure and Characteristics of the Hepatitis B Virus Gene in Mother-Infant Pairs in Parts of China.Expression and Purification of Recombinant Hepatitis Delta Virus (HDV) Antigen for Use in a Diagnostic ELISA for HDV Infection Using the High-Density Fermentation Strategy in Escherichia coli.Epitope-based recombinant diagnostic antigen to distinguish natural infection from vaccination with hepatitis A virus vaccines.The long-term efficacy, 13-23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in China.Evolution and genetic characterization of hepatitis A virus isolates in China.Efficient encapsulation of Fe₃O₄ nanoparticles into genetically engineered hepatitis B core virus-like particles through a specific interaction for potential bioapplications.Molecular epidemiological study of hepatitis B virus genotypes in Southwest, China.High expression of small hepatitis D antigen in Escherichia coli and ELISA for diagnosis of hepatitis D virus.Prevalence and risk factors of hepatitis C among former blood donors in rural China.Modularized Peptides Modified HBc Virus-Like Particles for Encapsulation and Tumor-Targeted Delivery of Doxorubicin.Design of Fusion Proteins for Efficient and Soluble Production of Immunogenic Ebola Virus Glycoprotein in Escherichia coli.Improved Stable Indocyanine Green (ICG)-Mediated Cancer Optotheranostics with Naturalized Hepatitis B Core Particles.Intranasal vaccination with ebola virus GP amino acids 258-601 protects mice against lethal challengeInvestigation of the risk factors associated with the failure of hepatitis B vaccination of neonates in Yunnan province, China
P50
Q28543439-46ABFB91-5C8C-4B4F-9C44-210E21CC2839Q30377094-996E1509-51C1-44DF-94E2-1FC3585F0D57Q30379017-5FC8782F-65F4-4D00-B607-8FE8DC421F36Q30382129-565D2175-A176-4D88-AFCF-8F1D60A4E35FQ31138256-ABCF2BF5-1347-405C-9FB9-E9CCD0E29624Q33332232-27B3568E-E1A6-4CA8-953F-8BBBC136BC9CQ33842386-431FCA7F-7A1D-486D-BBF8-41CB1C24E038Q33907592-DD1BC167-0F8F-4880-95B9-560DA55148DFQ34434631-42AC53F5-8540-4BF4-A832-B7C8830E6E82Q34758759-0A6A0F8A-AC88-4264-92BF-AC58DA53B848Q34999311-5039C5F8-E7CD-4414-8C37-8D6C16350758Q35165283-900AB8A0-DD3B-45F3-9A6E-80A34FB0832CQ35391544-CA72F1D9-1AD5-4829-9E8E-8B247EE2982CQ35729069-FD13BA0F-9D69-44B7-84A9-2F96FF7D38E5Q37110039-A37A4773-2D95-493C-96FA-9F4F65B230C7Q37254383-8F5434EC-EBCB-4A00-8E2E-B08FDD786EF1Q37277904-E04BB251-2542-4AA7-82FB-9DB7312B4860Q37519574-48BA0144-CECC-46A2-9525-27739B890C06Q37519579-749EC1EB-82DC-4F6F-984C-8BFA70AF3020Q37519606-F1A3EFB3-3427-4E20-837F-2377A817B3D3Q37591589-DC30E1AF-E5B6-4087-A790-BCCEA05DCD24Q37681184-9FDD8A23-CEAA-4508-87D9-91A955141B80Q38129156-F725D6E8-6A71-4888-937F-F3E2DF70A92BQ39033664-7445C8B1-6126-45A0-B7E9-1E2E092E6664Q39089043-952FA3CD-9146-4CED-90B6-1D1831358539Q39847914-AA81CC61-60EA-4570-AC48-59A828A1077CQ40402185-F3C3E9CE-B8A9-47CF-97E9-2597DCEB4A3EQ40596002-2BC60673-B298-453C-B53A-A0C443B696ACQ40748824-A0E04825-646F-4B84-8BD8-B94376F85154Q41355357-863EC9CC-AABE-4F8F-ACF1-C6FFF32468B2Q41519783-A0FDFEAD-120A-4735-B670-96E1E3F3516AQ42198029-88A4DFBE-1CDE-40D6-8840-6BF07E980295Q42216575-1C46F630-AF5B-41C8-8B1A-28014AB2FDCEQ42261261-C484D45B-9054-440B-B50B-ABDA0E304A64Q42982208-3BB4A411-E8D5-4959-BF48-427425B18425Q47221605-089D5143-F855-4DE7-A477-A4F8584611C1Q51784470-49771429-6C66-492D-8F0B-802CBE1C4E99Q54203027-5C9E5842-F4A3-47EC-BE1A-DD3F82AF4103Q57091827-F186343E-B8B8-470B-AA68-F46F32078651Q57184788-F7B58A50-9FF7-4186-A2EC-6496B6FEFBFB
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Shengli Bi
@en
Shengli Bi
@nl
type
label
Shengli Bi
@en
Shengli Bi
@nl
prefLabel
Shengli Bi
@en
Shengli Bi
@nl
P31
P496
0000-0002-0380-5790